Ridruejo E - Search Results

1

Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges.

Piñero F, Poniachik J, Ridruejo E, Silva M. Piñero F, et al. Among authors: ridruejo e. World J Gastroenterol. 2018 Oct 7;24(37):4224-4229. doi: 10.3748/wjg.v24.i37.4224. World J Gastroenterol. 2018. PMID: 30310255 Free PMC article.

2

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Polaris Observatory HCV Collaborators. Polaris Observatory HCV Collaborators. Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16. Lancet Gastroenterol Hepatol. 2017. PMID: 28404132 Review.

3

Hepatocellular carcinoma in renal transplant patients.

Ridruejo E, Mandó OG, Dávalos M, Díaz C, Vilches A. Ridruejo E, et al. Transplant Proc. 2005 Jun;37(5):2086-8. doi: 10.1016/j.transproceed.2005.03.010. Transplant Proc. 2005. PMID: 15964346

4

[Statement of the Argentinian Concensus on Hepatitis C 2007].

Fassio E, Schroder T; Asociación Argentina para el Estudio de las Enfermedades del Hígado. Fassio E, et al. Acta Gastroenterol Latinoam. 2008 Mar;38(1):56-74. Acta Gastroenterol Latinoam. 2008. PMID: 18533358 Spanish. No abstract available.

5

Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study.

Fassio E, Díaz S, Santa C, Reig ME, Martínez Artola Y, Alves de Mattos A, Míguez C, Galizzi J, Zapata R, Ridruejo E, de Souza FC, Hernández N, Pinchuk L; Multicenter Group for Study of Hepatocarcinoma in Latin America; Asociación Latinoamericana para el Estudio del Hígado (ALEH). Fassio E, et al. Among authors: ridruejo e. Ann Hepatol. 2010 Jan-Mar;9(1):63-9. Ann Hepatol. 2010. PMID: 20332549 Free article.

6

Thioctic acid-induced acute cholestatic hepatitis.

Ridruejo E, Castiglioni T, Silva MO. Ridruejo E, et al. Ann Pharmacother. 2011 Jul;45(7-8):e43. doi: 10.1345/aph.1Q035. Epub 2011 Jun 13. Ann Pharmacother. 2011. PMID: 21672886

7

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Ridruejo E, Adrover R, Silva MO. Ridruejo E, et al. Hepatology. 2011 Sep 2;54(3):1104-5; author reply 1105. doi: 10.1002/hep.24498. Hepatology. 2011. PMID: 21721024 No abstract available.

8

Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice.

Ridruejo E, Adrover R, Cocozzella D, Reggiardo MV, Estepo C, Schroder T, Paz S, Mendizábal M, Fainboim H, Mandó OG, Silva MO. Ridruejo E, et al. Int J Clin Pract. 2011 Aug;65(8):866-70. doi: 10.1111/j.1742-1241.2011.02719.x. Int J Clin Pract. 2011. PMID: 21762311

9

Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin.

Ridruejo E, Solano A, Marciano S, Galdame O, Adrover R, Cocozzella D, Delettieres D, Martínez A, Gadano A, Mandó OG, Silva MO. Ridruejo E, et al. Ann Hepatol. 2011 Oct-Dec;10(4):452-7. Ann Hepatol. 2011. PMID: 21911885 Free article.

10

Entecavir in the treatment of chronic hepatitis B in kidney transplantation.

Ridruejo E, Adrover R, Mandó OG, Silva MO. Ridruejo E, et al. J Hepatol. 2012 Apr;56(4):997-8; author reply 999. doi: 10.1016/j.jhep.2011.09.019. Epub 2011 Nov 7. J Hepatol. 2012. PMID: 22075262 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters